Ablation of myocardial tissues with nanosecond pulsed electric fields
View Patent ↗An apparatus and methods for performing ablation of myocardial tissues are disclosed. The apparatus includes a plurality of ablation electrode configurations to which nanosecond pulsed electric fields are applied. The methods relate to therapies to treat cardiac arrhythmias, such as, atrial fibrillation and scar-related ventricular tachycardia, amongst others. The affected myocardial tissues are ablated creating a plurality of lesions enabled by the nanosecond pulsed electric fields applied to either penetrating electrodes, endo-endo electrodes, or endo-epi electrodes. Different electrophysiological tests are performed to assess the application of nanosecond pulsed electric field ablation to specific desired tissue location within the heart. Test results show the potential to overcome limitations of current ablation therapies, thereby providing patients and doctors a superior treatment for cardiac arrhythmias.
1. Method of ablating myocardial tissue, comprising:
contacting a first electrode to a first section of myocardial tissue;
contacting a second electrode to a second section of myocardial tissue;
applying a nanosecond pulsed electric field (nsPEF) between the first and the second electrodes to form a non-conducting lesion having substantially uniform ablated tissue volume; and
controlling a width of the non-conducting lesion at least in part by a spacing between the first and the second electrodes.
2. The method of claim 1 , wherein the width is in a range of about 3 mm to about 6 mm.
3. The method of claim 1 , wherein the spacing between the first and the second electrodes is of about 2 mm or more.
4. The method of claim 1 , wherein a first electrode diameter is from about 100 μm to about 1,000 μm.
5. The method of claim 1 , the method comprising controlling the width of the non-conducting lesion at least in part by shock parameters.
6. The method of claim 1 , wherein pulse amplitude of the nanosecond pulsed electric field is in the range of about 1 kV to about 100 kV.
7. The method of claim 1 , wherein the non-conducting lesion treats one or more of atrial fibrillation, ventricular tachycardia, or other arrhythmias.
8. The method of claim 1 , the method comprising using a catheter to deliver the first electrode to the first section of myocardial tissue.
9. The method of claim 8 , wherein the catheter is an endocardial catheter or an endothoracic catheter.
10. The method of claim 8 , the method comprising using a second catheter to deliver the second electrode to the second section.
11. The method of claim 1 , wherein at least one of the first and the second electrode is a penetrating electrode.
12. The method of claim 1 , wherein at least one of the first and the second electrode is a surface electrode.
13. The method of claim 1 , the method comprising forming a plurality of adjacent, non-conducting lesions such that lesions of the plurality of lesions collectively are sufficient to prevent or at least substantially reduce occurrence of arrhythmia conditions.
14. The method of claim 13 , wherein at least some of the plurality of lesions are side-by-side or overlap.
15. The method of claim 1 , the method comprising obtaining an assessment of results of the formation of the non-conducting lesion.
16. The method of claim 15 , wherein the assessment comprises one or more tests of results of nsPEF ablation.
17. The method of claim 1 , wherein a treatment time of the ablation of myocardial tissue is reduced to less than 1 second.
18. The method of claim 1 , the method comprising forming the non-conductive lesion with a minimal amount of tissue to be ablated.
19. The method of claim 1 , the method comprising forming the non-conducting lesion having substantially uniform ablated tissue volume in up to 2 seconds.
20. The method of claim 1 , wherein the first section and the second section are sections of endocardium.